The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease - Top-Institutions - MDSpire

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • By

  • Yingte Wang

  • Hong Li

  • Jing Zhou

  • Saiyao Zhao

  • Airong Yang

  • Zhiming Li

  • May 8, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital and Brigham and Women’s Hospital
    Massachusetts General Hospital and Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Neurosurgery

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #3

    Alzheimer’s Disease Neuroimaging Initiative
    Alzheimer’s Disease Neuroimaging Initiative

    N/A, N/A

    Key Differentiators

    • Neuroimaging
    • Alzheimer's Research

Original Source(s)

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • by Yingte Wang, Hong Li, Jing Zhou, Saiyao Zhao, Airong Yang, Zhiming Li

  • May 8, 2026

Related Content

Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study

Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia

Synthetic Microbial Communities: a novel Emerging Models for Dissecting Gut microbiota-Host Interactions in Neurodegenerative Diseases